We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BBLGW market cap is 189.61M. The company's latest EPS is USD -2.8555 and P/E is -0.62.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.15M | -3.04M | -2.08M | -1.16M | -903k |
Net Income | -3.71M | -1.77M | -1.92M | -1.55M | -866k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.45M | -825k | -1.1M | -3.67M | -9.43M |
Net Income | -3.43M | -1.83M | -1.61M | -1.49M | -8.95M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 6.78M | 7.62M | 4.98M | 3.74M | 3.84M |
Total Liabilities | 4.01M | 1.93M | 1.18M | 832k | 165k |
Total Equity | 2.77M | 5.69M | 3.79M | 2.91M | 3.68M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 31k | 0 | 6.68M | 8.5M | 3.74M |
Total Liabilities | 11.9M | 13.69M | 100k | 2.55M | 832k |
Total Equity | -11.87M | -13.69M | 6.58M | 5.95M | 2.91M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1.35M | -4.98M | -7.54M | -9.56M | -1.3M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | 4.45M | 4.45M | 5.04M | 1.5M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.25M | -427k | -1.23M | -3.57M | -9.56M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 2.32M | 403k | 7.9M | 4.43M | 5.04M |
Market Cap | 189.61M |
Price to Earnings Ratio | -0.62 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.82 |
Price to Book Ratio | 1.9 |
Dividend Yield | - |
Shares Outstanding | 3.13M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 69.58 (100%) |
Company Name | Bone Biologics Corporation |
Address |
1013 centre road wilmington, delaware 19805 |
Website | https://www.bonebiologics.com |
Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions